July 27 2005 - TRINITY CLINIC-CORSICANA UROLOGIST RECEIVES CLINICAL INVESTIGATOR ACCREDITATION
Press Release - July 27,
TRINITY CLINIC-CORSICANA UROLOGIST RECEIVES CLINICAL INVESTIGATOR ACCREDITATION
July 27, 2005
TRINITY CLINIC-CORSICANA PHYSICIAN RECEIVES
CLINICAL INVESTIGATOR CERTIFICATION
CORSICANA, TX – Anthony J. Perri, MD, director, clinical research operations, Trinity Clinic-Corsicana and a physician with Trinity Clinic Urology, received notification from the Drug Information Association (DIA) that he completed all requirements for certification as a Certified Clinical Investigator (CCI). Dr. Perri joins only eight other CCI’s in Texas and fewer than 100 in the U.S. and Canada.
Clinical trials are pre-market testing programs for drugs. During these trials, an investigational drug is given to patients and evaluated for its safety and effectiveness in treating, preventing, or diagnosing a specific disease or condition. The results of this testing are the most important factor in the approval or disapproval of a new drug.
“The clinical investigator has the role of overseeing the safety of patients who enroll in clinical research, as well as for a large part of the overall way in which a clinical trial is conducted,” said Dr. Perri. “The training of clinical investigators is essential so that quality sponsored clinical research can lead to a proven medication being made available to the public.”
Currently, urology patients in the North Central and east Texas areas are being offered the opportunity to participate in a study that could help find new treatment options for those suffering from interstitial cystitis (IC), a chronic and painful bladder disorder. Trinity Clinic-Corsicana is one of two Texas sites (the other is in Fort Worth) participating in a new clinical trial to examine the effectiveness of an investigational drug that could potentially offer additional treatment options for a disorder that currently has few available.
Trinity Clinic-Corsicana is one of several leading medical facilities around the country to participate in the clinical research study that will examine the safety and effectiveness of an investigational treatment for IC. Patients diagnosed with IC as well as those who have bladder and pelvic pain, urinary frequency and urgency are encouraged to call Kelli Ritterbach at 903-872-4611 ext 5107 or 1-800-441-1367 ext 5107.
For more information on services available through Trinity Mother Frances Health System, visit www.tmfhs.org.
# # #